1984•Journal of Antimicrobial ChemotherapyRequires access

Treatment of pseudomembranous colitis and antibiotic-associated diarrhoea

D. W. Burdon

Open publisher page 4 citations

Abstract

Pseudomembranous colitis is caused by release of toxins from Clostridium difficile when it colonizes the large intestine. This clostridium is susceptible to concentrations of vancomycin which are readily attained in the colon after oral administration. When vancomycin is given orally to infected patients in a dose of 125 mg every 6 h, a rapid clinical cure can be expected. Some patients may relapse after the vancomycin is stopped, but a further course of treatment will control symptoms.

About this research paper

What this paper is about

Pseudomembranous colitis is caused by release of toxins from Clostridium difficile when it colonizes the large intestine. This clostridium is susceptible to concentrations of vancomycin which are readily attained in the colon after oral administration. When vancomycin is given orally to infected patients in a dose of 125 mg every 6 h, a rapid clinical cure can be expected. Some patients may relapse after the vancomycin is stopped, but a further course of treatment will control symptoms.

Why it matters

OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Pseudomembranous colitis is caused by release of toxins from Clostridium difficile when it colonizes the large intestine. This clostridium is susceptible to concentrations of vancomycin which are readily attained in the colon after oral administration. When vancomycin is given orally to infected patients in a dose of 125 mg every 6 h, a rapid clinical cure can be expected. Some patients may relapse after the vancomycin is stopped, but a further course of treatment will control symptoms.

Key concepts: Pseudomembranous colitis, Clostridium difficile, Vancomycin, Antibiotics, Medicine, Colitis, Gastroenterology, Clostridium

Related papers

Back to paper searchBrowse research topicsOriginal source
Treatment of pseudomembranous colitis and antibiotic-associated diarrhoea — Research Paper | ScholarLens